Skip to main content
Equibles

JACOBS LEVY EQUITY MANAGEMENT, INC

Position in ANIK — Anika Therapeutics, Inc.

CIK 884414 FLORHAM PARK, NJ
Back to ANIK Full portfolio

Position in ANIK

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,182,463
-$669,128 QoQ
Shares Held
217,530
-18.1% QoQ
Ownership
1.63%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#17
of 134 holders
Holding Since
Jun 2022
8 quarters on record
Voting authority Sole 84% Shared 0% None 16%

Common Shares in ANIK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

JACOBS LEVY EQUITY MANAGEMENT, INC holds $311,064,443 across 17 Drug Manufacturers - Specialty & Generic names. ANIK ranks #9 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
 726,112 $122,378,916
2 LNTH
Lantheus Holdings, Inc.
 699,583 $77,611,738
3 ZTS
Zoetis Inc.
 579,079 $41,612,616
4 LQDA
Liquidia Corp
 240,752 $19,195,156
5 IRWD
Ironwood Pharmaceuticals Inc
 4,065,964 $17,117,708
6 BIOA
BioAge Labs, Inc.
 377,085 $9,242,353
7 PCRX
Pacira BioSciences, Inc.
 199,800 $5,068,926
8 AKBA
Akebia Therapeutics, Inc.
 4,273,026 $4,871,249

All Filings in ANIK

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,182,463 217,530
2026-03-31 $3,851,591 265,627
2025-12-31 $1,879,571 195,585
2025-09-30 $1,032,251 109,814
2025-06-30 $1,262,596 119,338
2025-03-31 $2,048,273 136,279
2024-12-31 $1,958,344 118,976
2022-06-30 $365,981 16,397